Cargando…
The effects of motion on the dose distribution of proton radiotherapy for prostate cancer
Proton radiotherapy of the prostate basal or whole seminal vesicles using scattering delivery systems is an effective treatment of prostate cancer that has been evaluated in prospective trials. Meanwhile, the use of pencil beam scanning (PBS) can further reduce the dose in the beam entrance channels...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716555/ https://www.ncbi.nlm.nih.gov/pubmed/22584166 http://dx.doi.org/10.1120/jacmp.v13i3.3639 |
_version_ | 1783283971423993856 |
---|---|
author | Qamhiyeh, Sima Geismar, Dirk Pöttgen, Christoph Stuschke, Martin Farr, Jonathan |
author_facet | Qamhiyeh, Sima Geismar, Dirk Pöttgen, Christoph Stuschke, Martin Farr, Jonathan |
author_sort | Qamhiyeh, Sima |
collection | PubMed |
description | Proton radiotherapy of the prostate basal or whole seminal vesicles using scattering delivery systems is an effective treatment of prostate cancer that has been evaluated in prospective trials. Meanwhile, the use of pencil beam scanning (PBS) can further reduce the dose in the beam entrance channels and reduce the dose to the normal tissues. However, PBS dose distributions can be affected by intra‐ and interfractional motion. In this treatment planning study, the effects of intra‐ and interfractional organ motion on PBS dose distributions are investigated using repeated CT scans at close and distant time intervals. The minimum dose ([Formula: see text]) and the dose to 2% and 98% of the volumes ([Formula: see text] and [Formula: see text]), as well as EUD in the clinical target volumes (CTV), is used as measure of robustness. In all patients, [Formula: see text] was larger than 96% and [Formula: see text] was less than 106% of the prescribed dose. The combined information from [Formula: see text] , [Formula: see text] and EUD led to the conclusion that there are no relevant cold spots observed in any of the verification plans. Moreover, it was found that results of single field optimization are more robust than results from multiple field optimizations. PACS numbers: 87.55.D‐, 87.55.de, 87.53.Bn, 87.55.dk, 87.55.ne |
format | Online Article Text |
id | pubmed-5716555 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57165552018-04-02 The effects of motion on the dose distribution of proton radiotherapy for prostate cancer Qamhiyeh, Sima Geismar, Dirk Pöttgen, Christoph Stuschke, Martin Farr, Jonathan J Appl Clin Med Phys Radiation Oncology Physics Proton radiotherapy of the prostate basal or whole seminal vesicles using scattering delivery systems is an effective treatment of prostate cancer that has been evaluated in prospective trials. Meanwhile, the use of pencil beam scanning (PBS) can further reduce the dose in the beam entrance channels and reduce the dose to the normal tissues. However, PBS dose distributions can be affected by intra‐ and interfractional motion. In this treatment planning study, the effects of intra‐ and interfractional organ motion on PBS dose distributions are investigated using repeated CT scans at close and distant time intervals. The minimum dose ([Formula: see text]) and the dose to 2% and 98% of the volumes ([Formula: see text] and [Formula: see text]), as well as EUD in the clinical target volumes (CTV), is used as measure of robustness. In all patients, [Formula: see text] was larger than 96% and [Formula: see text] was less than 106% of the prescribed dose. The combined information from [Formula: see text] , [Formula: see text] and EUD led to the conclusion that there are no relevant cold spots observed in any of the verification plans. Moreover, it was found that results of single field optimization are more robust than results from multiple field optimizations. PACS numbers: 87.55.D‐, 87.55.de, 87.53.Bn, 87.55.dk, 87.55.ne John Wiley and Sons Inc. 2012-05-10 /pmc/articles/PMC5716555/ /pubmed/22584166 http://dx.doi.org/10.1120/jacmp.v13i3.3639 Text en © 2012 The Authors. This is an open access article under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/3.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Radiation Oncology Physics Qamhiyeh, Sima Geismar, Dirk Pöttgen, Christoph Stuschke, Martin Farr, Jonathan The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title | The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title_full | The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title_fullStr | The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title_full_unstemmed | The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title_short | The effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
title_sort | effects of motion on the dose distribution of proton radiotherapy for prostate cancer |
topic | Radiation Oncology Physics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716555/ https://www.ncbi.nlm.nih.gov/pubmed/22584166 http://dx.doi.org/10.1120/jacmp.v13i3.3639 |
work_keys_str_mv | AT qamhiyehsima theeffectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT geismardirk theeffectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT pottgenchristoph theeffectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT stuschkemartin theeffectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT farrjonathan theeffectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT qamhiyehsima effectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT geismardirk effectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT pottgenchristoph effectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT stuschkemartin effectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer AT farrjonathan effectsofmotiononthedosedistributionofprotonradiotherapyforprostatecancer |